- Home
- IMNM vs CSLMU Comparison
IMNM vs CSLMU Comparison
Compare IMNM & CSLMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- CSLMU
- Stock Information
- Founded
- IMNM 2006
- CSLMU N/A
- Country
- IMNM United States
- CSLMU
- Employees
- IMNM N/A
- CSLMU 3
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- CSLMU
- Sector
- IMNM Health Care
- CSLMU
- Exchange
- IMNM Nasdaq
- CSLMU NYSE
- Market Cap
- IMNM 747.7M
- CSLMU N/A
- IPO Year
- IMNM 2020
- CSLMU N/A
- Fundamental
- Price
- IMNM $12.45
- CSLMU $11.69
- Analyst Decision
- IMNM Strong Buy
- CSLMU
- Analyst Count
- IMNM 4
- CSLMU 0
- Target Price
- IMNM $28.75
- CSLMU N/A
- AVG Volume (30 Days)
- IMNM 801.6K
- CSLMU N/A
- Earning Date
- IMNM 11-07-2024
- CSLMU N/A
- Dividend Yield
- IMNM N/A
- CSLMU N/A
- EPS Growth
- IMNM N/A
- CSLMU N/A
- EPS
- IMNM N/A
- CSLMU N/A
- Revenue
- IMNM $10,784,000.00
- CSLMU N/A
- Revenue This Year
- IMNM N/A
- CSLMU N/A
- Revenue Next Year
- IMNM N/A
- CSLMU N/A
- P/E Ratio
- IMNM N/A
- CSLMU N/A
- Revenue Growth
- IMNM 62.73
- CSLMU N/A
- 52 Week Low
- IMNM $6.93
- CSLMU N/A
- 52 Week High
- IMNM $30.96
- CSLMU N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 34.11
- CSLMU 50.83
- Support Level
- IMNM $12.90
- CSLMU $10.72
- Resistance Level
- IMNM $13.91
- CSLMU $12.99
- Average True Range (ATR)
- IMNM 0.86
- CSLMU 0.01
- MACD
- IMNM -0.25
- CSLMU 0.01
- Stochastic Oscillator
- IMNM 4.87
- CSLMU 100.00
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About CSLMU CSLM ACQUISITION CORP
CSLM Acquisition Corp, formerly Consilium Acquisition Corp I Ltd is a blank check company.